UE: Bayer niega intención de ‘forzar’ uso de semillas modificadas tras compra de Monsanto
Werner Baumann, CEO de la firma alemana Bayer AG, ha declarado una promesa pública, asegurando que no utilizarán su posible adquisición de Monsanto Co. para forzar el uso de semillas modificadas genéticamente en Europa, donde los consumidores se han mostrado escépticos respecto a dichos productos agrícolas.
Featured News
Judge Sets March 2027 Trial in Paramount-WBD Merger Challenge
Aug 5, 2026 by
CPI
FTC Scrutinizes Proposed $3.5 Billion Veterinary Products Merger
Aug 4, 2026 by
CPI
Apple Seeks Court Order in AI Trade Secrets Dispute With OpenAI
Aug 4, 2026 by
CPI
Australian Competition Watchdog Accepts EnergyAustralia Undertaking Over Retail Rule Breach
Aug 4, 2026 by
CPI
South Korea Weighs Sweeping Antitrust Overhaul
Aug 4, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes